Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CRDLCRDL
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CARDIOL THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 333,900 shares of CRDL (CARDIOL THERAPEUTICS INC), worth $353,934 as of 2026-Q2. The position was increased (+0.5% shares).

Current Value

$353,934

Current Shares

333,900

Total Value Change

+$307,982

Total Shares Change

+298,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
333,900
+0.5%
$353,9340.0%$1.06
16
2026-Q1
Increased
332,400
+1.2%
$448,7400.0%$1.01
24
2025-Q4
Increased
328,500
+2.1%
$313,3230.0%$0.97
16
2025-Q3
Increased
321,800
+459.6%
$344,3260.0%$1.14
26
2025-Q2
Increased
57,500
+46.7%
$78,2000.0%$1.41
20
2025-Q1
Increased
39,200
+9.2%
$38,0160.0%$0.96
15
2024-Q4
New
35,900
-
$45,9520.0%$1.28
31

Other major holders of CRDL: Mirae Asset Global Investments Co., Ltd., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used